First Time Loading...

Celltrion Inc
KRX:068270

Watchlist Manager
Celltrion Inc Logo
Celltrion Inc
KRX:068270
Watchlist
Price: 189 000 KRW 0.8%
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one Celltrion Inc stock under the Base Case scenario is 168 925.01 KRW. Compared to the current market price of 189 000 KRW, Celltrion Inc is Overvalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
168 925.01 KRW
Overvaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

18
P/S
P/S
Price to Sales
18
vs History
44
vs Industry
35
Median 3Y
11.3
Median 5Y
17.9
Industry
8.3
Forward
12.8
More Details
73.1
P/E
P/E
Price to Earnings
73.1
vs History
31
vs Industry
2
Median 3Y
43.5
Median 5Y
60.8
Industry
26.8
Forward
41.7
More Details
72.9
P/OCF
P/OCF
Price to OCF
72.9
vs History
38
vs Industry
2
Median 3Y
70.4
Median 5Y
68.9
Industry
23.3
More Details
651.1
P/FCFE
P/FCFE
Price to FCFE
651.1
vs History
6
vs Industry
0
Median 3Y
51.2
Median 5Y
123.5
Industry
21.4
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
92
vs Industry
41
Median 3Y
5.9
Median 5Y
7.3
Industry
2.6
More Details
18.4
EV/S
EV/S
Enterprise Value to Sales
18.4
vs History
39
vs Industry
29
Median 3Y
11
Median 5Y
17.9
Industry
7.5
Forward
13.1
More Details
38.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
38.2
vs History
23
vs Industry
17
Median 3Y
21.7
Median 5Y
32.1
Industry
9.2
More Details
44.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
44.7
vs History
23
vs Industry
2
Median 3Y
26.1
Median 5Y
36.6
Industry
4.5
Forward
35.5
More Details
61.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
61.6
vs History
28
vs Industry
2
Median 3Y
35.2
Median 5Y
47.5
Industry
4.4
Forward
47.6
More Details
74.7
EV/OCF
EV/OCF
Enterprise Value to OCF
74.7
vs History
34
vs Industry
2
Median 3Y
70.8
Median 5Y
69.5
Industry
5.6
More Details
218.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
218.9
vs History
25
vs Industry
1
Median 3Y
48.8
Median 5Y
112.1
Industry
3.4
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
92
vs Industry
48
Median 3Y
4.8
Median 5Y
6.3
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Celltrion Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6
US
Abbvie Inc
NYSE:ABBV
289.2B USD 5.3 60 13 19.9
US
Amgen Inc
NASDAQ:AMGN
166.7B USD 5.9 24.8 17.9 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.7B USD 8 26.5 17.8 19.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.7 21.6 26.8
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.8 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 7 -10.1 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.7B USD 3.3 27.1 13.9 17.4
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.